Literature DB >> 31156813

Semiautomated aseptic preparation of patient-individual antineoplastic intravenous solutions: first experiences in a German hospital pharmacy.

Tilman Schoening1, Adelia Artes1, Martin Ehmann1, Mieke Mertens1, Michael Ober1, Torsten Hoppe-Tichy1.   

Abstract

OBJECTIVES: In 2013, the PharmaHelp device was introduced to daily patient care at the University Hospital of Heidelberg in order to improve process and staff safety and health. It is a semiautomated device located in a safety workbench for aseptic preparation with weight-and-visual-supported process check as well as radio-frequency identification of bags and vials.
METHODS: After qualification and a training period, several high-admixture-volume drugs were chosen stepwise to be prepared by the device. During a reporting period of 6 months, the number of processed production runs and produced bags were assessed as well as the productivity per hour of the device based on the processed admixing volume and time consumption for manual preprocessing and postprocessing steps.
RESULTS: Weight conformity tests of 246 processed bags in 11 admixing-volume ranges showed 99.19% with a deviation of <5%. Validation of the automated preparation process with 40 media fills showed no microbiological growth. Daily patient care production in the first 6 months led to a nearly similar weight accuracy and an average productivity of 22.5 preparations per running hour of the device at an average admixing volume of 39.6 mL, excluding manual preprocessing and postprocessing tasks. Time consumption for all manual steps was about 76 min per run.
CONCLUSIONS: The automated admixing process of the device showed remarkable effectivity and a satisfying accuracy, but the manual preprocessing and postprocessing steps are time consuming, which is associated with the local environment, and has to be reorganised.

Entities:  

Keywords:  PHARMACY MANAGEMENT (PERSONNEL)

Year:  2015        PMID: 31156813      PMCID: PMC6451565          DOI: 10.1136/ejhpharm-2015-000655

Source DB:  PubMed          Journal:  Eur J Hosp Pharm        ISSN: 2047-9956


  8 in total

1.  Implementation of an i.v.-compounding robot in a hospital-based cancer center pharmacy.

Authors:  Angela W Yaniv; Scott J Knoer
Journal:  Am J Health Syst Pharm       Date:  2013-11-15       Impact factor: 2.637

Review 2.  Centralized intravenous additive services (CIVAS): the state of the art in 2010.

Authors:  J-D Hecq
Journal:  Ann Pharm Fr       Date:  2010-12-30

3.  Robotized compounding of oncology drugs in a hospital pharmacy.

Authors:  Elisabetta Palma; Celestino Bufarini
Journal:  Int J Pharm Compd       Date:  2014 Sep-Oct

4.  Safe handling of cytotoxics: guideline recommendations.

Authors:  A C Easty; N Coakley; R Cheng; M Cividino; P Savage; R Tozer; R E White
Journal:  Curr Oncol       Date:  2015-02       Impact factor: 3.677

5.  Impact of robotic antineoplastic preparation on safety, workflow, and costs.

Authors:  Andrew C Seger; William W Churchill; Carol A Keohane; Caryn D Belisle; Stephanie T Wong; Katelyn W Sylvester; Megan A Chesnick; Elisabeth Burdick; Matt F Wien; Michael C Cotugno; David W Bates; Jeffrey M Rothschild
Journal:  J Oncol Pract       Date:  2012-09-25       Impact factor: 3.840

6.  Environmental contamination by cyclophosphamide preparation: Comparison of conventional manual production in biological safety cabinet and robot-assisted production by APOTECAchemo.

Authors:  Rudolf Schierl; Carla Masini; Svenja Groeneveld; Elke Fischer; Antje Böhlandt; Valeria Rosini; Demis Paolucci
Journal:  J Oncol Pharm Pract       Date:  2014-09-16       Impact factor: 1.809

7.  Automated preparation of chemotherapy: quality improvement and economic sustainability.

Authors:  Carla Masini; Oriana Nanni; Sara Antaridi; Davide Gallegati; Mattia Marri; Demis Paolucci; Martina Minguzzi; Mattia Altini
Journal:  Am J Health Syst Pharm       Date:  2014-04-01       Impact factor: 2.637

8.  Robotic system for i.v. antineoplastic drug preparation: description and preliminary evaluation under simulated conditions.

Authors:  D D Cote; M G Torchia
Journal:  Am J Hosp Pharm       Date:  1989-11
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.